Hillsdale Investment Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-50
Closed -$11K 627
2014
Q4
$11K Buy
+50
New +$9.94K ﹤0.01% 495
2014
Q3
Sell
-60
Closed -$10K 616
2014
Q2
$10K Sell
60
-2,630
-98% -$409K ﹤0.01% 494
2014
Q1
$334K Hold
2,690
0.09% 156
2013
Q4
$299K Hold
2,690
0.09% 205
2013
Q3
$243K Buy
2,690
+90
+3% +$8.08K 0.07% 261
2013
Q2
$219K Buy
+2,600
New +$270K 0.07% 275

Other funds holding AGN

Hillsdale Investment Management's AGN Position: Q1 2015 in Review

Hillsdale Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 50 shares — an estimated $11K sold.

Hillsdale Investment Management first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $334K in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Hillsdale Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Hillsdale Investment Management sold 50 Allergan Inc shares in Q1 2015, an estimated $11K.
  • Hillsdale Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Hillsdale Investment Management's Allergan Inc position peaked at $334K in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Hillsdale Investment Management's 13F filing for Q1 2015, filed 12 May 2015.